Looks like a good bottOm is forming ahead of the next placement. Final report on south afrIcan trial coming. Will be interesting to see any viral cOntrol correlation to duration since infection or immune system strength. The Aussie trials are just too good for it to be a fluke alOng with the excellent cOntrol early on.
Price is well below value of transgene license alone. But this may not be realized for at least six months. Will be an interesting one again later this year. For now, a nice long bottoming formation in the making.
Looks like a good bottOm is forming ahead of the next placement....
Add to My Watchlist
What is My Watchlist?
